Rein Therapeutics Inc (RNTX)

$1.25 -0.10 (-7.41%)
Market Cap 31.46M
Revenue (ttm) 0.00
Net Income (ttm) -62.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 342,000
Avg Vol 1,153,872
Day's Range N/A - N/A
Shares Out 23.31M
Stochastic %K 17%
Beta 1.15
Analysts Strong Sell
Price Target $8.00

Company Profile

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 802 1989
Address:
12407 N. Mopac Expy., Suite 250 #390, Austin, United States
MomentumWins
MomentumWins Nov. 14 at 2:39 PM
$RNTX this is too small to trade along indexes. it was 1.61 before the fda removed the hold. you expect it to be higher. They have lots of cash to survive
0 · Reply
d_risk
d_risk Nov. 14 at 1:11 PM
$RNTX - Rein Therapeutics, Inc. - 10Q - Updated Risk Factors RNTX warns it needs significant new funding to continue operations and, given ongoing losses and limited cash, there’s substantial doubt about its ability to remain a going concern. #Biotechnology #CashFlow #GoingConcern #FundingChallenges #FinancialRisk 🟢 Added 🟠 Removed https://d-risk.ai/RNTX/10-Q/2025-11-14
0 · Reply
LollyTech
LollyTech Nov. 10 at 7:38 PM
$RNTX going up now
0 · Reply
MomentumWins
MomentumWins Nov. 10 at 3:06 PM
$RNTX how come this is lower than Phase2 hold clearance ? $SPY
0 · Reply
Zackpedia
Zackpedia Nov. 7 at 6:00 PM
$RNTX You could’ve sold when I alerted and bought back at 1.5 if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
BrianWindsor
BrianWindsor Nov. 6 at 2:18 PM
New data on LTI-03 for idiopathic pulmonary fibrosis (#IPF) just posted. The study reports LTI-03 was well tolerated and showed reductions in multiple fibrosis-related biomarkers, plus signals that may help preserve lung cells needed for repair. We think it’s encouraging validation as we continue our global Phase 2 RENEW trial. Check out the full press release here: https://bit.ly/43dhAqW $RNTX #Biotech #ClinicalTrials #PulmonaryFibrosis
0 · Reply
Therealone777
Therealone777 Nov. 6 at 1:28 PM
$BIYA — $RNTX News and Ready go
0 · Reply
Therealone777
Therealone777 Nov. 6 at 1:24 AM
$RNTX Insights? predictions?
0 · Reply
Zackpedia
Zackpedia Nov. 4 at 12:34 PM
$RNTX You could’ve sold above 2 when I alerted and bought back at 1.4 now if you wanted.
1 · Reply
StockScanners
StockScanners Nov. 4 at 2:15 AM
$RNTX reached 3.15
0 · Reply
Latest News on RNTX
Why Is Rein Therapeutics Stock Trading Higher On Monday?

Nov 3, 2025, 1:17 PM EST - 11 days ago

Why Is Rein Therapeutics Stock Trading Higher On Monday?

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Oct 9, 2025, 7:30 AM EDT - 5 weeks ago

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis

Sep 17, 2025, 7:30 AM EDT - 2 months ago

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Aug 19, 2025, 8:00 AM EDT - 3 months ago

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Aug 14, 2025, 5:00 PM EDT - 3 months ago

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Jun 24, 2025, 10:11 AM EDT - 5 months ago

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Jun 12, 2025, 5:18 PM EDT - 5 months ago

US FDA puts on hold Rein Therapeutics' lung disease drug trial

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 27, 2025, 7:00 AM EDT - 6 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQV

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

May 19, 2025, 4:51 PM EDT - 6 months ago

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 4:09 PM EDT - 6 months ago

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 12, 2025, 7:00 AM EDT - 6 months ago

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

May 1, 2025, 7:00 AM EDT - 7 months ago

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Apr 30, 2025, 4:05 PM EDT - 7 months ago

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Apr 28, 2025, 7:00 AM EDT - 7 months ago

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Apr 23, 2025, 7:00 AM EDT - 7 months ago

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Apr 15, 2025, 7:00 AM EDT - 7 months ago

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Apr 7, 2025, 4:17 PM EDT - 7 months ago

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MomentumWins
MomentumWins Nov. 14 at 2:39 PM
$RNTX this is too small to trade along indexes. it was 1.61 before the fda removed the hold. you expect it to be higher. They have lots of cash to survive
0 · Reply
d_risk
d_risk Nov. 14 at 1:11 PM
$RNTX - Rein Therapeutics, Inc. - 10Q - Updated Risk Factors RNTX warns it needs significant new funding to continue operations and, given ongoing losses and limited cash, there’s substantial doubt about its ability to remain a going concern. #Biotechnology #CashFlow #GoingConcern #FundingChallenges #FinancialRisk 🟢 Added 🟠 Removed https://d-risk.ai/RNTX/10-Q/2025-11-14
0 · Reply
LollyTech
LollyTech Nov. 10 at 7:38 PM
$RNTX going up now
0 · Reply
MomentumWins
MomentumWins Nov. 10 at 3:06 PM
$RNTX how come this is lower than Phase2 hold clearance ? $SPY
0 · Reply
Zackpedia
Zackpedia Nov. 7 at 6:00 PM
$RNTX You could’ve sold when I alerted and bought back at 1.5 if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
BrianWindsor
BrianWindsor Nov. 6 at 2:18 PM
New data on LTI-03 for idiopathic pulmonary fibrosis (#IPF) just posted. The study reports LTI-03 was well tolerated and showed reductions in multiple fibrosis-related biomarkers, plus signals that may help preserve lung cells needed for repair. We think it’s encouraging validation as we continue our global Phase 2 RENEW trial. Check out the full press release here: https://bit.ly/43dhAqW $RNTX #Biotech #ClinicalTrials #PulmonaryFibrosis
0 · Reply
Therealone777
Therealone777 Nov. 6 at 1:28 PM
$BIYA — $RNTX News and Ready go
0 · Reply
Therealone777
Therealone777 Nov. 6 at 1:24 AM
$RNTX Insights? predictions?
0 · Reply
Zackpedia
Zackpedia Nov. 4 at 12:34 PM
$RNTX You could’ve sold above 2 when I alerted and bought back at 1.4 now if you wanted.
1 · Reply
StockScanners
StockScanners Nov. 4 at 2:15 AM
$RNTX reached 3.15
0 · Reply
Zackpedia
Zackpedia Nov. 3 at 10:03 PM
$RNTX You could’ve sold when I alerted and bought back at 1.6 if you wanted, hit Follow and subscribe to get my alerts on time and make money
0 · Reply
BearTamerTrading
BearTamerTrading Nov. 3 at 9:36 PM
🚀 Free Trade Monday — Premarket Power Plays 🔥 The following plays were discussed and called live during premarket before the crowd: 🔥 $RNTX — profit-taking pullback after prior biotech surge 🔥 $NCRA — momentum cool-off after +95% digital-treasury announcement rally 🔥 $CRBU — steady base forming after gene-editing news cycle 🔥 $MSPR — continued volatility as micro-cap healthcare floats rotate Members were already in position before the volume spike 💪 If you missed it, watch the replay for proof — testimonials are in the comments ⬇️ 🎥 Replay: https://www.youtube.com/live/DRHvjrWez2c?si=f0HfqlcnxNdRmbD9
5 · Reply
topstockalerts
topstockalerts Nov. 3 at 8:46 PM
$RNTX following closely
0 · Reply
Noodles1981
Noodles1981 Nov. 3 at 8:10 PM
$AREC … $RNTX may also run to 2.20+
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 3 at 7:54 PM
$RNTX IMO this run will end eventually...
0 · Reply
jjrrjjrr
jjrrjjrr Nov. 3 at 7:18 PM
#stocks $PHIO $NCRA $CURR $RNTX $LGCL 🤫 NFA
0 · Reply
topstockalerts
topstockalerts Nov. 3 at 7:09 PM
$RNTX small caps continue to run..
0 · Reply
Zackpedia
Zackpedia Nov. 3 at 6:00 PM
$RNTX Exactly!
0 · Reply
_www_larval_com_
_www_larval_com_ Nov. 3 at 4:43 PM
$RNTX has reversed -6% lower to 23% (~40Mv) in the last few minutes, follow for more volatility.
0 · Reply
GladiatorSwings
GladiatorSwings Nov. 3 at 4:40 PM
$TERN $PHIO $RAY.X $RNTX $NUAI
0 · Reply
Dukefurer
Dukefurer Nov. 3 at 4:32 PM
$RNTX Still holding 😍
0 · Reply
Stripette
Stripette Nov. 3 at 4:26 PM
$RNTX Boom!
0 · Reply